Concomitant and sequential administration of YM155 and docetaxel enhances apoptosis and tumor regression in human tumor xenograft models

被引：0
|
作者：
Yamanaka, Kentaro [1 ]
Nakahara, Takahito [1 ]
Kita, Aya [1 ]
Takeuchi, Masahiro [1 ]
Kinoyama, Isao [1 ]
Matsuhisa, Akira [1 ]
Koutoku, Hiroshi [1 ]
Sasamata, Masao [1 ]
机构：
[1] Astellas Pharma Inc, Tsukuba, Japan
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3520S / 3521S
页数：2
相关论文
共 34 条
  • [1] YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
    Nakahara, Takahito
    Yamanaka, Kentaro
    Hatakeyama, Shinji
    Kita, Aya
    Takeuchi, Masahiro
    Kinoyama, Isao
    Matsuhisa, Akira
    Nakano, Kenji
    Shishido, Takao
    Koutoku, Hiroshi
    Sasamata, Masao
    ANTI-CANCER DRUGS, 2011, 22 (05) : 454 - 462
  • [2] YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression
    Mir, Roser
    Stanzani, Elisabetta
    Martinez-Soler, Fina
    Villanueva, Alberto
    Vidal, August
    Condom, Enric
    Ponce, Jordi
    Gil, Joan
    Tortosa, Avelina
    Gimenez-Bonafe, Pepita
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 211 - 220
  • [3] Tumor regression induced by YM155, a novel, small molecule survivin suppressant, in experimental human lung tumor models.
    Nakahara, Takahito
    Takeuchi, Masahiro
    Kinoyama, Isao
    Kita, Aya
    Yamanaka, Kentaro
    Matsuhisa, Akira
    Sasamata, Masao
    CANCER RESEARCH, 2006, 66 (08)
  • [4] YM155 inhibits tumor growth and enhances chemosensitivity to cisplatin in osteosarcoma
    Gao, J. -Z.
    Chen, F. -H.
    Wang, L.
    Wei, H.
    Meng, S. -L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (11) : 2062 - 2069
  • [5] Survivin Inhibitor YM155 Induces Apoptosis and Inhibits Tumor Growth of Human Gastric Carcinoma
    Cheng, Xiaojiao
    Ding, Yanfei
    Zhu, Liming
    Qiao, MInmin
    Ye, Jing
    Jiang, Shihu R.
    Tu, Shuiping
    GASTROENTEROLOGY, 2013, 144 (05) : S168 - S168
  • [6] Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models
    Kaneko, Naoki
    Kita, Aya
    Nakahara, Takahito
    Nakata, Mari
    Koutoku, Hiroshi
    Sasamata, Masao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 260P - 260P
  • [7] YM155, a novel survivin suppressant, induced downregulation of survivin and potent antitumor activities in experimental human prostate tumor xenograft models.
    Nakahara, T
    Takeuchi, M
    Isao, K
    Tsuyoshi, M
    Akira, M
    Kita, A
    Tominaga, F
    Yamanaka, K
    Sasamata, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9082S - 9083S
  • [8] YM155: a small molecule survivin suppressant with potent antitumor effect in human cancer xenograft models
    Kita, Aya
    Nakahara, Takahito
    Takeuchi, Masahiro
    Kinoyama, Isao
    Matsuhisa, Akira
    Yamanaka, Kentaro
    Nakata, Mari
    Kaneko, Naoki
    Koutoku, Hiroshi
    Sasamata, Masao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 32P - 32P
  • [9] Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model
    Murakami, Yoshihiro
    Matsuya, Takahiro
    Kita, Aya
    Yamanaka, Kentaro
    Noda, Akihiro
    Mitsuoka, Keisuke
    Nakahara, Takahito
    Miyoshi, Sosuke
    Nishimura, Shintaro
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (02) : 221 - 226
  • [10] Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
    Tao, Yan-Fang
    Lu, Jun
    Du, Xiao-Juan
    Sun, Li-Chao
    Zhao, Xuan
    Peng, Liang
    Cao, Lan
    Xiao, Pei-Fang
    Pang, Li
    Wu, Dong
    Wang, Na
    Feng, Xing
    Li, Yan-Hong
    Ni, Jian
    Wang, Jian
    Pan, Jian
    BMC CANCER, 2012, 12
1234